Finance

Beta
Lists
CAPR:NASDAQ
Capricor Therapeutics Inc
$26.71
-4.44%
(-1.24) 1D
$27.23
+1.95% (+0.52)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAPR...
Open
$27.88
High
$27.95
Low
$26.56
Mkt. cap
1.55B
Avg. vol.
999.99K
Volume
578.22K
52-wk high
$40.37
52-wk low
$4.30
EPS
-$2.31
Beta
0.39
Shares outstanding
57.91M
No. of employees
231
Open
$27.88
High
$27.95
Low
$26.56
Mkt. cap
1.55B
Avg. vol.
999.99K
Volume
578.22K
52-wk high
$40.37
52-wk low
$4.30
EPS
-$2.31
Beta
0.39
Shares outstanding
57.91M
No. of employees
231
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to CAPR in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CAPR in the last 3 months.
Highest
Current $26.71
$63.00 (+135.87%)
Average
$54.50 (+104.04%)
Lowest
$38.00 (+42.27%)
News stories
From sources across the web
About Capricor Therapeutics Inc
CEOLinda Marban
Employees231
Founded2005
Headquarters-
SectorBiotechnology
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.59 / -$0.54
-8.92%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
22.05M
20.36M
23.13M
27.38M
Cost of revenue
22.05M
20.36M
23.13M
27.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
5.92M
6.02M
9.40M
Operating expense
5.67M
5.92M
6.02M
9.40M
Total operating expenses
27.72M
26.28M
29.16M
36.77M
Operating income
-27.72M
-26.28M
-29.16M
-36.77M
Other non operating income
14.99K
6.74K
11.20K
8.14K
EBT including unusual items
-25.91M
-24.57M
-30.17M
-33.94M
EBT excluding unusual items
-25.91M
-24.56M
-30.17M
-33.86M
Income tax expense
-
-
1.60K
-
Effective tax rate
-
-
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-25.91M
-24.57M
-30.17M
-33.94M
Net profit margin
-
-
-
-
Earnings per share
-0.57
-0.54
-0.62
-0.59
Interest and investment income
1.79M
1.71M
2.02M
2.90M
Interest expense
-
-
-3.05M
-
Net interest expenses
1.79M
1.71M
-1.02M
2.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.23M
-25.79M
-28.65M
-36.24M
Gain or loss from assets sale
-
6.85K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more